1.5 minute read
Starting December 23, 2024, all covered entities and their business associates will need to adhere to stricter HIPAA privacy protections specifically for reproductive health care....
1.5 minute read
Starting December 23, 2024, all covered entities and their business associates will need to adhere to stricter HIPAA privacy protections specifically for reproductive health care....
2.5 minute read
Open enrollment is a crucial time for employees to make decisions about their benefits, impacting their health and financial well-being. However, many rush through this process. A...
1 minute read
U.S. employers predict a 5.8% rise in health benefit costs for 2025, according to Mercer’s 2024 National Survey of Employer-sponsored Health Plans. This is the third year in a row that...
8 minute read
Discover how your employee leave policy could be influencing your ability to attract and retain top talent. Navigating the complexities of different leave types and their organizational...
3.5 minute read
On September 9, 2024, the Departments of Labor, Health and Human Services, and the Treasury (Departments) released a final rule to strengthen the Mental Health Parity and Addiction...
1 minute read
On September 6, 2024, the IRS unveiled Revenue Procedure 2024-35, which updates the contribution percentage for 2025 to determine the affordability of an employer’s health plan under...
5.5 minute read
Meeting the creditable coverage standard could be tougher in 2025 due to a richer Part D standard benefit. Plan sponsors with rich prescription drug coverage may remain unaffected,...
2 minute read
Clear and effective communication of benefits during open enrollment and throughout the year is vital. When employers provide concise and transparent information, they empower their...
1.5 minute read
On August 15, the Department of Health and Human Services (HHS) and top drugmakers agreed to lower prices on the first 10 drugs subject to Medicare price negotiations. Drug discounts...
1 minute read
A recent Business Group on Health (BGH) survey revealed that the increasing interest and spending on glucagon-like peptide-1 (GLP-1) drugs are driving up healthcare costs in 2025.